REGINA MIRACLE: Interim Report 2024/25

HKEXDec 20, 2024 19:30 · Announcements

Selected Announcement | Sino Biopharm's Class 1 innovative drug approved for new indications; LAKAI Pharmaceutical completes the placement of 17.636 million shares, raising approximately 0.23 billion Hong Kong dollars.

The innovative drug GLP-1R/GCGR dual agonist CMS-D005 from cms has received notification of clinical trial approval; Multiple Digital Intelligence is set to launch an IPO from November 28 to December 3, planning to globally issue 25.774 million shares.

cls.cnNov 28, 2024 08:10

REGINA MIRACLE To Go Ex-Dividend On December 10th, 2024 With 0.025 HKD Dividend Per Share

November 27th (Beijing Time) - $REGINA MIRACLE(02199.HK)$ is trading ex-dividend on December 10th, 2024.Shareholders of record on December 11th, 2024 will receive 0.025 HKD dividend per share on

Futu NewsNov 27, 2024 17:05

Regina Miracle Announces Interim Dividend for 2024

TipRanksNov 27, 2024 16:41

Regina Miracle (02199.HK): The interim profit attributable to shareholders is 67.619 million Hong Kong dollars, with an interim dividend of 2.5 Hong Kong cents.

As of September 30, 2024, regina miracle (02199.HK) announced that in the six months ended, it achieved revenue of 3.978 billion Hong Kong dollars, a year-on-year increase of 12.21%; gross profit was 0.938 billion Hong Kong dollars, a year-on-year increase of 11.31%; net profit attributable to owners of the company was 67.619 million Hong Kong dollars, a year-on-year decrease of 36.7%; basic and diluted earnings per share were 5.5 Hong Kong cents, and an interim dividend of 2.5 Hong Kong cents per ordinary share was declared.

Gelonghui FinanceNov 27, 2024 16:35

Regina miracle (02199) will distribute a mid-term dividend of HKD 0.025 per share on December 24.

Regina miracle (02199) announced that it will distribute dividends on December 24, 2024, for the period ending September 30, 2024...

Zhitong FinanceNov 27, 2024 16:32